In acute coronavirus disease 19 (COVID‐19) patients, effective clinical risk stratification has
important implications on treatment and therapeutic resource distribution. This article …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an array of
neurologic and neuropsychiatric symptoms in the acute and post-acute phase of infection …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is responsible for
coronavirus disease of 2019 (COVID‐19) that infected more than 760 million people …

Tools for predicting COVID-19 outcomes enable personalized healthcare, potentially easing
the disease burden. This collaborative study by 15 institutions across Europe aimed to …

Since Toll-like receptors (TLRs) recognize the earliest signs of infection or cell damage, they
play fundamental roles in innate immunity. This review summarizes the numerous studies on …

ABSTRACT COVID-19 is a contagious, severe acute respiratory disease caused by the
coronavirus named SARS-CoV-2. In this review, we have updated the nature and evolution …

The retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) play a crucial role as pattern-
recognition receptors within the innate immune system. These receptors, present in various …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
etiological agent responsible for the onset of coronavirus disease 2019 (COVID-19), elicits a …

Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes
coronavirus disease 2019 (COVID-19) has a high incidence of spread. On January 30 …

Predominantly antibody deficiencies (PADs) are inborn disorders characterized by immune
dysregulation and increased susceptibility to infections. Response to vaccination, including …